Vor Biopharma Inc.
General ticker "VOR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.3B (TTM average)
Vor Biopharma Inc. follows the US Stock Market performance with the rate: 25.3%.
Estimated limits based on current volatility of 2.1%: low 7.61$, high 8.35$
Factors to consider:
- Total employees count: 168 (+26.3%) as of 2023
- Top business risk factors: Insufficient funding, Regulatory and compliance, Cybersecurity threats, Limited operating history, Labor/talent shortage/retention
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [8.21$, 25.88$]
- 2025-12-31 to 2026-12-31 estimated range: [5.60$, 18.21$]
Financial Metrics affecting the VOR estimates:
- Negative: with PPE of -11.5 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -148.44 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term VOR quotes
Long-term VOR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $93.42MM | $126.04MM | $121.19MM |
| Operating Income | $-93.42MM | $-126.04MM | $-121.19MM |
| Non-Operating Income | $1.32MM | $8.17MM | $4.27MM |
| R&D Expense | $64.55MM | $94.31MM | $93.31MM |
| Income(Loss) | $-92.09MM | $-117.86MM | $-116.91MM |
| Profit(Loss)* | $-92.09MM | $-117.86MM | $-116.91MM |
| Stockholders Equity | $250.61MM | $150.72MM | $96.66MM |
| Assets | $299.37MM | $198.13MM | $142.89MM |
| Operating Cash Flow | $-85.14MM | $-100.29MM | $-99.66MM |
| Capital expenditure | $8.46MM | $1.07MM | $0.23MM |
| Investing Cash Flow | $-94.09MM | $71.01MM | $96.86MM |
| Financing Cash Flow | $117.14MM | $2.94MM | $53.39MM |
| Earnings Per Share** | $-46.57 | $-35.08 | $-34.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.